STAAR Surgical Company Provided sales Guidance for the fourth quarter and full year ended December 28, 2018. For the quarter, the Company expects fourth quarter ICL net sales to increase approximately 42% over the prior year period. Total net sales for the fourth quarter are expected to be approximately $31.2 million. For the full year of 2018, total net sales are expected to be approximately $124.0 million, representing approximately 37% growth over fiscal 2017.